Advertisement
Table 1 Baseline demographic and clinical characteristics
| Characteristic | Placebo | PS | Omega-3 | PS + Omega-3 | P value |
|---|---|---|---|---|---|
| n = 28 | n = 30 | n = 35 | n = 41 | ||
| Female (%) | 17 (60.71) | 12 (0.40) | 17 (48.57) | 23 (56.10) | 0.39 |
| Age (years) | 56.18 ± 4.06 | 56.17 ± 7.17 | 58.94 ± 7.21 | 55.63 ± 7.44 | 0.16 |
| HT (cm) | 162.52 ± 8.72 | 163.53 ± 8.41 | 164.23 ± 9.03 | 162.24 ± 8.06 | 0.746 |
| Weight (kg) | 69.82 ± 10.95 | 69.52 ± 10.48 | 69.54 ± 11.81 | 69.61 ± 10.46 | 1 |
| BMI (kg/m2) | 26.45 ± 3.81 | 26.18 ± 4.71 | 25.68 ± 2.98 | 26.43 ± 3.39 | 0.81 |
| Waistline (cm) | 94.84 ± 9.05 | 90.1 ± 6.71 | 90.4 ± 8.78 | 90.85 ± 9.69 | 0.136 |
| Systolic pressure (mmHg) | 132.36 ± 11.81 | 137.43 ± 12.91 | 136.69 ± 10.31 | 138.76 ± 14.57 | 0.218 |
| Diastolic pressure (mmHg) | 84.07 ± 11.15 | 85.63 ± 9.5 | 85.91 ± 10.61 | 84.63 ± 9.3 | 0.876 |
| FPG (mmol/l) | 6.49 ± 0.28 | 6.44 ± 0.23 | 6.56 ± 0.27 | 6.50 ± 0.26 | 0.369 |
| FINS (mU/L) | 10.28 ± 4.13 | 10.15 ± 3.14 | 9.85 ± 4.29 | 10.22 ± 5.47 | 0.98 |
| HOMA-IR | 2.96 ± 1.19 | 2.9 ± 0.89 | 2.86 ± 1.21 | 2.96 ± 1.58 | 0.983 |
| HbA1c (%) | 6.49 ± 0.43 | 6.21 ± 0.69 | 6.29 ± 0.74 | 6.36 ± 0.85 | 0.487 |
| TC (mmol/l) | 5.29 ± 0.82 | 5.42 ± 0.88 | 5.39 ± 0.62 | 5.35 ± 1.16 | 0.95 |
| TG (mmol/l) | 2.05 ± 0.71 | 2.07 ± 0.94 | 2.06 ± 0.84 | 2.07 ± 0.79 | 0.857 |
| HDL-C (mmol/l) | 1.22 ± 0.23 | 1.14 ± 0.25 | 1.19 ± 0.17 | 1.17 ± 0.23 | 0.632 |
| LDL-C (mmol/l) | 3.11 ± 0.90 | 2.56 ± 0.97 | 3.00 ± 0.63 | 2.98 ± 0.80 | 0.058 |
| Hs-CRP (mg/L) | 1.48 ± 0.69 | 1.13 ± 0.33 | 1.10 ± 0.85 | 1.11 ± 0.82 | 0.13 |
| IL-6 (pg/ml) | 3.03 ± 1.19 | 2.83 ± 1.14 | 2.98 ± 1.32 | 2.85 ± 1.36 | 0.9 |
| Body fat rate (%) | 32.68 ± 9.12 | 29.26 ± 6.97 | 29.65 ± 7.47 | 29.87 ± 8.44 | 0.353 |
| Visceral fat rating | 12.07 ± 4.06 | 11.47 ± 4.41 | 12.03 ± 4.27 | 12.07 ± 4.62 | 0.934 |
